I'm looking forward to the half year results. Contract manufacturing has been consistently growing over the last couple of years and Impromy has been gaining good traction:
https://ajp.com.au/news/pharmacies-key-weight-loss-success/
I'm also impressed they have been able to pay down high debt levels with existing cash flow over the last couple of years (instead of needing to raise new equity).
Add to My Watchlist
What is My Watchlist?